Stockreport

Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer [Globe and Mail, The (Toronto, Canada)]

Oncolytics Biotech Inc. - Common Shares  (ONCY) 
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.oncolyticsbiotech.com
PDF SAN DIEGO and CALGARY, AB Feb. 18, 2025 /CNW/ -- Oncolytics Biotech Inc. ( NASDAQ ONCY TSX ONC ), a leading clinical-stage company specializing in immunotherapy for onc [Read more]